Potentially Reduce Major Adverse Cardiovascular Events

20 Mar 2025
Apply

AMR Daphne is currently conducting a clinical study of an investigational medication to potentially reduce major cardiovascular events.

Qualified participants must:

be ages 18 and older with a history of a major cardiovascular event Or

be ages 50 and older who are at high risk for having their first major cardiovascular event

meet other study criteria

Qualified participants will receive:

all study-related care and the investigational medication or placebo at no cost

compensation up to $2,550.00 for time and travel

Learn more by calling AMR Daphne at 251-999-8523 or by visiting www.amrdaphne.com today!

Full-time
  • ID: #53677685
  • State: Alabama Mobile 36601 Mobile USA
  • City: Mobile
  • Salary: USD TBD TBD
  • Showed: 2025-03-20
  • Deadline: 2025-05-19
  • Category: Science/biotech
Apply